Parameters | Univariate | ||
---|---|---|---|
RR | 95% CI | p value | |
Age | |||
> 15 | 0.78 | 0.25–2.42 | 0.670 |
Sex | |||
male | 0.61 | 0.19–1.96 | 0.407 |
AJCC stage (vs 2A) | |||
2B | 1.48 | 0.48–4.56 | 0.496 |
Location (vs femur) | |||
Tibia | 0.74 | 0.23–2.34 | 0.605 |
Others | 0.68 | 0.07–6.79 | 0.739 |
Pathologic subtype (vs osteoblastic) | |||
Fibroblastic | <0.01 | N/A | 0.998 |
Chondroblastic | 1.54 | 0.25–9.30 | 0.641 |
Others | 1.54 | 0.13–18.25 | 0.734 |
Histologic response | |||
Poor | 2.97 | 1.04–8.45 | 0.041* |
SUV0 | |||
< 6.2 | 1.81 | 0.52–6.28 | 0.353 |
SUV1 | |||
≥ 4.6 | 3.76 | 0.97–14.57 | 0.055 |
SUV2 | |||
≥ 5.9 | 3.89 | 1.49–10.15 | 0.005* |
Δ%SUV01 | |||
≥− 39.8% | 4.23 | 1.21–14.78 | 0.024* |
Δ%SUV02 | |||
≥− 54.1% | 6.39 | 1.45–28.10 | 0.014* |